Published in Indian J Ophthalmol on May 18, 2011
Low-fluence photodynamic therapy for early onset choroidal neovascular membrane following laser in situ keratomileusis. Indian J Ophthalmol (2012) 1.14
Changing paradigms of anti-VEGF in the Indian scenario. Indian J Ophthalmol (2014) 0.85
Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology (2003) 1.78
Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol (2006) 1.49
Influence of treatment parameters on selectivity of verteporfin therapy. Invest Ophthalmol Vis Sci (2006) 1.28
Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol (2006) 1.21
Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retina (2008) 1.10
Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy. Am J Ophthalmol (2005) 0.93
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol (2006) 0.90
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol (2007) 0.87
Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia. Can J Ophthalmol (2008) 0.85
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Repeat gas insufflation for successful closure of idiopathic macular hole following failed primary surgery. Indian J Ophthalmol (2014) 2.78
Programme planning and screening strategy in retinopathy of prematurity. Indian J Ophthalmol (2003) 2.33
Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology (2008) 2.17
Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina (2013) 2.17
Current approaches to diagnosis and management of ocular lesions in human immunodeficiency virus positive patients. Indian J Ophthalmol (2002) 2.10
Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy. Indian J Ophthalmol (2012) 1.89
Endophthalmitis caused by Acinetobacter calcoaceticus. A profile. Indian J Ophthalmol (2003) 1.77
The effects of renal transplantation on diabetic retinopathy: clinical course and visual outcomes. Indian J Ophthalmol (2013) 1.56
Hemi-central retinal artery occlusion in young adults. Indian J Ophthalmol (2010) 1.49
World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer (2008) 1.48
Knowledge of diabetes and diabetic retinopathy among rural populations in India, and the influence of knowledge of diabetic retinopathy on attitude and practice. Rural Remote Health (2008) 1.48
Influence of dietary-fibre intake on diabetes and diabetic retinopathy: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (report 26). Clin Experiment Ophthalmol (2011) 1.43
Trace elements iron, copper and zinc in vitreous of patients with various vitreoretinal diseases. Indian J Ophthalmol (2004) 1.43
Clinical profile and immunological status of cytomegalovirus retinitis in organ transplant recipients. Indian J Ophthalmol (2002) 1.40
Off-label use of bevacizumab in retinopathy of prematurity. Retina (2009) 1.40
Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology. Ophthalmic Epidemiol (2005) 1.40
Transpupillary thermotherapy for choroidal neovascular membrane in age related macular degeneration. Indian J Ophthalmol (2004) 1.38
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood (2011) 1.36
Submacular hemorrhage: a study amongst Indian eyes. Indian J Ophthalmol (2012) 1.29
Retinoblastoma: one world, one vision. Pediatrics (2008) 1.29
Coats' disease: an Indian perspective. Indian J Ophthalmol (2010) 1.26
Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. Ophthalmology (2003) 1.18
The clinical spectrum and treatment outcome of retinoblastoma in Indian children. J Pediatr Ophthalmol Strabismus (2005) 1.17
Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr (2010) 1.16
Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for Stage 4 retinopathy of prematurity. Indian J Ophthalmol (2009) 1.16
Eales disease--an update. Surv Ophthalmol (2002) 1.15
Fractured Ozurdex™ implant in the vitreous cavity. Indian J Ophthalmol (2012) 1.14
The cost-utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology (2012) 1.14
Optical coherence tomography characteristics in eyes with optic pit maculopathy. Retina (2013) 1.11
Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol (2008) 1.11
Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol (2009) 1.11
Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity. Pediatr Res (2003) 1.11
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Retina (2006) 1.09
Patient satisfaction with tele-ophthalmology versus ophthalmologist-based screening in diabetic retinopathy. J Telemed Telecare (2006) 1.09
Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries. Br J Ophthalmol (2007) 1.08
Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study. Retina (2005) 1.07
Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic Genet (2008) 1.06
Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia. Indian J Ophthalmol (2010) 1.06
A 32 kb critical region excluding Y402H in CFH mediates risk for age-related macular degeneration. PLoS One (2011) 1.05
Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India (2010) 1.05
Diabetic retinopathy screening model for rural population: awareness and screening methodology. Rural Remote Health (2005) 1.04
Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Syndr (2011) 1.04
Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy? Ophthalmic Res (2011) 1.02
The tele-screening model for diabetic retinopathy: evaluating the influence of mydriasis on the gradability of a single-field 45 degrees digital fundus image. Telemed J E Health (2007) 1.01
Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications (2012) 1.01
Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications (2002) 1.01
Late recurrence of tumor necessitating enucleation in an adult onset retinoblastoma. Ophthalmic Genet (2012) 1.00
The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy: response to Ahmed et al. Diabetes Care (2007) 1.00
Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series. Oman J Ophthalmol (2012) 1.00
Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet (2003) 0.99
Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population. Invest Ophthalmol Vis Sci (2007) 0.98
Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Ophthalmology (2010) 0.97
Retinoblastoma in India : microsatellite analysis and its application in genetic counseling. Mol Diagn Ther (2007) 0.97
Patient satisfaction levels during teleophthalmology consultation in rural South India. Telemed J E Health (2006) 0.97
Transpupillary thermotherapy for large-sized subfoveal circumscribed choroidal hemangioma. Retina (2006) 0.97
Rapid progression of angioid streaks following intravitreal bevacizumab. Can J Ophthalmol (2009) 0.97
Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology (2004) 0.97
Hemorrhagic intraretinal macrocyst: Differential diagnoses and report of an unusual case. Oman J Ophthalmol (2011) 0.95
Identification of a novel splice-site mutation in the Lebercilin (LCA5) gene causing Leber congenital amaurosis. Mol Vis (2008) 0.94
Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India. Ophthalmic Genet (2007) 0.94
Multifocal lateral and fourth ventricular B-cell primary CNS lymphoma. Clin Neurol Neurosurg (2011) 0.94
Prevalence and risk factors for cataract in diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, report no. 17. Invest Ophthalmol Vis Sci (2010) 0.92
Diffuse anterior retinoblastoma with undetectable retinal involvement. J Pediatr Ophthalmol Strabismus (2011) 0.91
Management of peripheral polypoidal choroidal vasculopathy with intravitreal bevacizumab and indocyanine green angiography-guided laser photocoagulation. Indian J Ophthalmol (2012) 0.90
Detection of human papillomavirus DNA in retinoblastoma samples: a preliminary study. J Pediatr Hematol Oncol (2009) 0.90
Comparison between Humphrey Field Analyzer and Micro Perimeter 1 in normal and glaucoma subjects. Oman J Ophthalmol (2012) 0.90
Intra-arterial chemotherapy for retinoblastoma: First Indian report. Indian J Ophthalmol (2015) 0.89
Uveal melanoma presenting as cataract and staphyloma. Indian J Ophthalmol (2009) 0.89
Choroidal neovascularization associated with coloboma of the choroid: a series of three cases. Indian J Ophthalmol (2011) 0.89
Spectral-domain OCT and microperimeter characterization of morphological and functional changes in X-linked retinoschisis. Ophthalmic Surg Lasers Imaging (2009) 0.89
Effect of illumination on colour vision testing with Farnsworth-Munsell 100 hue test: customized colour vision booth versus room illumination. Korean J Ophthalmol (2010) 0.88
Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J Ophthalmol (2010) 0.88